ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Overview Fund Activity
Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

155 hedge funds and large institutions have $402M invested in Intercept Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 37 reducing their positions, and 18 closing their positions.

Holders
155
Holders Change
+12
Holders Change %
+8.39%
% of All Funds
2.68%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
59
Reduced
37
Closed
18
Calls
$43.8M
Puts
$22.5M
Net Calls
+$21.2M
Net Calls Change
+$1.66M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$21.8M
2
Millennium Management
2
Millennium Management
New York
$16.4M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$10.3M
4
Jane Street
4
Jane Street
New York
$4.05M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$3.99M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$13M
2
State Street
2
State Street
Massachusetts
$42.6M
3
Fuller & Thaler Asset Management
3
Fuller & Thaler Asset Management
California
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$12.5M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$2.43M
Name Market Value Shares Shares
Change 		Shares
Change %
State Street
1
State Street
Massachusetts
$42.6M 3,051,584 -425,048 -12%
BlackRock
2
BlackRock
New York
$41M 2,936,187 +217,833 +8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$37.8M 2,706,414 +197,255 +8%
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$21.8M 1,559,183 +1,431,883 +1,125%
Millennium Management
5
Millennium Management
New York
$16.4M 1,177,749 +845,142 +254%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$13M 934,378 -1,132,128 -55%
Morgan Stanley
7
Morgan Stanley
New York
$12.5M 897,973 -163,196 -15%
EAM
8
Eventide Asset Management
Massachusetts
$11.2M 800,000 – –
Jacobs Levy Equity Management
9
Jacobs Levy Equity Management
New Jersey
$10.9M 780,945 +135,254 +21%
Renaissance Technologies
10
Renaissance Technologies
New York
$10.3M 739,200 +345,800 +88%
Macquarie Group
11
Macquarie Group
Australia
$9.16M 655,940 +10,871 +2%
SB
12
Samsara BioCapital
California
$8.94M 640,688 – –
Two Sigma Advisers
13
Two Sigma Advisers
New York
$8.82M 632,100 +189,300 +43%
Rockefeller Capital Management
14
Rockefeller Capital Management
New York
$7.49M 536,764 +17,042 +3%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$6.25M 447,778 +10,571 +2%
Bank of America
16
Bank of America
North Carolina
$6.18M 443,163 +113,567 +34%
Two Sigma Investments
17
Two Sigma Investments
New York
$5.96M 427,436 +223,282 +109%
Nuveen Asset Management
18
Nuveen Asset Management
Illinois
$5.75M 412,026 +94,515 +30%
EAM
19
EULAV Asset Management
Florida
$5.51M 395,000 – –
Goldman Sachs
20
Goldman Sachs
New York
$5.2M 372,466 +4,931 +1%
Citadel Advisors
21
Citadel Advisors
Florida
$5.06M 363,061 +234,277 +182%
JAM
22
Jupiter Asset Management
United Kingdom
$4.78M 342,641 +15,088 +5%
CSS
23
Cubist Systematic Strategies
Connecticut
$4.66M 334,168 +261,412 +359%
Voloridge Investment Management
24
Voloridge Investment Management
Florida
$4.66M 333,729 +21,253 +7%
Citigroup
25
Citigroup
New York
$4.42M 316,927 +42,423 +15%
1
2 3 4 5